Anti-angiogenic Agents in Combination With Immune Checkpoint Inhibitors: A Promising Strategy for Cancer TreatmentYuxiao Song(Hubei Cancer Hospital), Bicheng Zhang(Renmin Hospital of Wuhan University)Frontiers in ImmunologyAugust 25, 202010.3389/fimmu.2020.01956Cited by 252SaveCiteExport RISWatch citationsRelated PapersGIDE is a mitochondrial E3 ubiquitin ligase that induces apoptosis and slows growth|Cell Research|2008|81Dihydroartemisinin sensitizes Lewis lung carcinoma cells to carboplatin therapy via p38 mitogen-activated protein kinase activation|Oncology Letters|2018|14